Related Experiment Video
Updated: Feb 17, 2026

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
Published on: January 31, 2018
A Poly-ADP-Ribose Trigger Releases the Auto-Inhibition of a Chromatin Remodeling Oncogene
Hari R Singh1, Aurelio P Nardozza1, Ingvar R Möller2
1Biomedical Center Munich, Faculty of Medicine, Ludwig-Maximilians-Universität München, Großhaderner Street 9, 82152 Planegg-Martinsried, Germany.
Abstract:
DNA damage triggers chromatin remodeling by mechanisms that are poorly understood. The oncogene and chromatin remodeler ALC1/CHD1L massively decompacts chromatin in vivo yet is inactive prior to DNA-damage-mediated PARP1 induction. We show that the interaction of the ALC1 macrodomain with the ATPase module mediates auto-inhibition. PARP1 activation suppresses this inhibitory interaction. Crucially, release from auto-inhibition requires a poly-ADP-ribose (PAR) binding macrodomain. We identify tri-ADP-ribose as a potent PAR-mimic and synthetic allosteric effector that abrogates ATPase-macrodomain interactions, promotes an ungated conformation, and activates the remodeler's ATPase. ALC1 fragments lacking the regulatory macrodomain relax chromatin in vivo without requiring PARP1 activation. Further, the ATPase restricts the macrodomain's interaction with PARP1 under non-DNA damage conditions. Somatic cancer mutants disrupt ALC1's auto-inhibition and activate chromatin remodeling. Our data show that the NAD+-metabolite and nucleic acid PAR triggers ALC1 to drive chromatin relaxation. Modular allostery in this oncogene tightly controls its robust, DNA-damage-dependent activation.
Insights
The oncogene ALC1 is auto-inhibited until DNA damage activates PARP1. A specific poly-ADP-ribose (PAR) mimic releases this inhibition, activating ALC1 for chromatin remodeling.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Biology
Background:
- DNA damage response involves chromatin remodeling.
- The oncogene ALC1 (CHD1L) is a chromatin remodeler activated by DNA damage.
- Mechanisms of ALC1 activation by DNA damage are not fully understood.
Purpose of the Study:
- To elucidate the auto-inhibition mechanism of ALC1.
- To identify the role of poly-ADP-ribose (PAR) in ALC1 activation.
- To investigate how cancer mutations affect ALC1 regulation.
Main Methods:
- Biochemical assays to study protein interactions.
- In vivo chromatin remodeling assays.
- Analysis of somatic cancer mutations in ALC1.
Main Results:
- ALC1 auto-inhibition is mediated by macrodomain-ATPase interaction.
- PARP1 activation and poly-ADP-ribose (PAR) binding release auto-inhibition.
- A tri-ADP-ribose mimic activates ALC1 by disrupting auto-inhibition.
- Cancer mutations in ALC1 impair auto-inhibition, leading to constitutive activation.
Conclusions:
- ALC1 activation is tightly regulated by modular allostery, controlled by DNA-damage-dependent PAR.
- The NAD+-metabolite PAR triggers ALC1-mediated chromatin relaxation.
- Dysregulated ALC1 auto-inhibition contributes to cancer development.
Related Concept Videos
Abnormal Proliferation
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation

